GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8F) » Definitions » PS Ratio

Biofrontera AG (XTER:B8F) PS Ratio : 0.74 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Biofrontera AG's share price is €0.342. Biofrontera AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €0.46. Hence, Biofrontera AG's PS Ratio for today is 0.74.

Good Sign:

Biofrontera AG stock PS Ratio (=0.74) is close to 10-year low of 0.68

The historical rank and industry rank for Biofrontera AG's PS Ratio or its related term are showing as below:

XTER:B8F' s PS Ratio Range Over the Past 10 Years
Min: 0.68   Med: 11.82   Max: 116.98
Current: 0.74

During the past 13 years, Biofrontera AG's highest PS Ratio was 116.98. The lowest was 0.68. And the median was 11.82.

XTER:B8F's PS Ratio is ranked better than
80.62% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 2.2 vs XTER:B8F: 0.74

Biofrontera AG's Revenue per Sharefor the three months ended in Sep. 2023 was €0.11. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €0.46.

Warning Sign:

Biofrontera AG revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Biofrontera AG was -12.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -13.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 20.90% per year.

During the past 13 years, Biofrontera AG's highest 3-Year average Revenue per Share Growth Rate was 50.30% per year. The lowest was -13.10% per year. And the median was 36.30% per year.

Back to Basics: PS Ratio


Biofrontera AG PS Ratio Historical Data

The historical data trend for Biofrontera AG's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG PS Ratio Chart

Biofrontera AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.37 6.57 5.30 2.91 3.56

Biofrontera AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 3.56 2.64 1.84 1.19

Competitive Comparison of Biofrontera AG's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofrontera AG's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera AG's PS Ratio distribution charts can be found below:

* The bar in red indicates where Biofrontera AG's PS Ratio falls into.



Biofrontera AG PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Biofrontera AG's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.342/0.462
=0.74

Biofrontera AG's Share Price of today is €0.342.
Biofrontera AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.46.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Biofrontera AG  (XTER:B8F) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Biofrontera AG PS Ratio Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofrontera AG (XTER:B8F) Business Description

Traded in Other Exchanges
Address
Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8F) Headlines

No Headlines